◆英語タイトル:ImmunoGen Inc (IMGN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7172
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
ImmunoGen Inc (ImmunoGen) is a clinical-stage biotechnology company that focuses on the development of antibody-drug conjugate therapies for the treatment of cancer. The company’s lead product candidate, mirvetuximab soravtansine, a folate receptor alpha (FRa) intended for the treatment of platinum-resistant ovarian cancer and other types of solid tumors, and in Phase 1b/2 testing in combination regimens. Its other pipeline products include IMGN779, a CD33-targeting product candidate for acute myeloid leukemia (AML); and IMGN632 for AML, B-cell acute lymphocytic leukemia, myelodysplastic syndrome and other CD123-positive malignancies. It also carries out early state programs in the areas of solid and liquid tumors. The company has partnership with various pharmaceutical companies to develop and commercialize anticancer compounds. ImmunoGen is headquartered in Waltham, Massachusetts, the US.
ImmunoGen Inc (IMGN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ImmunoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ImmunoGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ImmunoGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ImmunoGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ImmunoGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ImmunoGen Inc, Medical Equipment, Deal Details 10
Partnerships 10
Ventana Medical Systems Enters into Co-Development Agreement with ImmunoGen 10
Equity Offering 11
ImmunoGen Raises USD150.7 Million in Public Offering of Shares 11
ImmunoGen Raises USD108.4 Million in Public Offering of Shares 13
ImmunoGen Plans to Raise up to USD50 Million in Public Offering 15
ImmunoGen Inc – Key Competitors 16
ImmunoGen Inc – Key Employees 17
ImmunoGen Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Jul 27, 2018: ImmunoGen Reports Recent Progress and Second Quarter 2018 Operating Results 19
May 04, 2018: ImmunoGen Reports Recent Progress and First Quarter 2018 Operating Results 21
Feb 09, 2018: ImmunoGen Reports Pipeline Progress and 2017 Operating Results 23
Nov 03, 2017: ImmunoGen Reports Recent Progress and Third Quarter 2017 Operating Results 25
Jul 28, 2017: ImmunoGen Reports Recent Progress and Second Quarter 2017 Operating Results 27
May 05, 2017: ImmunoGen Reports Recent Progress and First Quarter 2017 Operating Results 29
Feb 17, 2017: ImmunoGen Reports Recent Progress and Operating Results for Six-Month Period and Quarter Ended December 31, 2016 31
Corporate Communications 33
Apr 25, 2018: ImmunoGen Appoints Blaine McKee as Executive Vice President and Chief Business Officer 33
Jan 23, 2017: ImmunoGen Announces Departure of Sandra Poole 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
List of Tables
ImmunoGen Inc, Medical Equipment, Key Facts, 2017 2
ImmunoGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ImmunoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ImmunoGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ImmunoGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ImmunoGen Inc, Deals By Market, 2012 to YTD 2018 8
ImmunoGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ventana Medical Systems Enters into Co-Development Agreement with ImmunoGen 10
ImmunoGen Raises USD150.7 Million in Public Offering of Shares 11
ImmunoGen Raises USD108.4 Million in Public Offering of Shares 13
ImmunoGen Plans to Raise up to USD50 Million in Public Offering 15
ImmunoGen Inc, Key Competitors 16
ImmunoGen Inc, Key Employees 17
ImmunoGen Inc, Subsidiaries 18
List of Figures
ImmunoGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ImmunoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ImmunoGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ImmunoGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ImmunoGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ImmunoGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ImmunoGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ImmunoGen Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8